We write in connection to the recent review article by Schuit et al. ([@B1]) on gene repression in the β-cell. Although most review articles display a natural (and forgivable) bias toward the authors' own contributions and point of view, we feel that this article goes well beyond the norm.

Firstly, the section entitled "How islet-specifically repressed genes were identified" is largely restricted to the authors' own work. This significantly distorts the true historical narrative. It fails to mention, in particular, that the founder members (*LDHA* and *MCT1/SLC16A1*) of what were later dubbed the "disallowed" group were, in fact, first identified in a systematic comparison of the metabolic enzymology of fluorescence-activated cell sorting--purified β-cells versus a range of insulinoma cells and a limited number of primary mouse tissues (notably liver and islet non--β-cells) in a collaboration between G.A.R. and Claes Wollheim reported in 1994 ([@B2]). A further article by Matschinksy and colleagues ([@B3]), which also demonstrated low levels of lactate dehydrogenase in a relatively well-differentiated β-cell line, also goes uncited, as well as a much earlier paper by Hellman et al. ([@B4]) suggesting lactate dehydrogenase activity may be unusually low in the islet.

An additional, and greater concern, is that the review by Schuit et al. ([@B1]) fails to cite the first bioinformatics analysis to provide a list of "disallowed" genes in the β-cell ([@B5]), referring instead only to the later article from the authors' own group ([@B6]). Similarities and differences between the gene lists generated by these two articles are therefore not discussed. Strikingly, both analyses indicate that *LDHA* and *MCT1* are probably the most strongly (selectively) repressed β-cell genes ([@B5],[@B6]), further emphasizing the importance of our original findings ([@B2]).
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